Shelley Orwick

18PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsMedical infection agents (incl. prions)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 02, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability.

Nadeen Anabtawi, Thomas Drabison, Alexander F Ham

|Sep 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Monica Cusan, Karilyn Larkin, Deedra Nicolet

|Aug 22, 2025
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895.

Jack C Stromatt, Eman A Ahmed, Thomas Drabison

|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.

Eric D Eisenmann, Ronan Swords, Ying Huang

|Jan 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies.

Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi

|Sep 30, 2024
CD37 in acute myeloid leukemia: a novel surface target for drug delivery.

Erin Jeremy, Esthela Artiga, Sara Elgamal

Pageof 3

Frequent Collaborators

12 joint publications

James S Blachly

7 joint publications

Krzysztof Mrózek

7 joint publications

Alice S Mims

6 joint publications

Sharyn D Baker